Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine phosphatase localized to the mitochondrion 1 (PTPMT1) is a dual-specificity phosphatase exclusively localized to the mitochondrial inner membrane, with a critical role in the biosynthesis of cardiolipin by dephosphorylating phosphatidylglycerol phosphate. It is indispensable for mitochondrial integrity, respiration, and proper embryonic development, as knockout models result in embryonic lethality and severe mitochondrial dysfunction. While it belongs to the protein tyrosine phosphatase family, its endogenous substrate is a lipid intermediate, not a protein. PTPMT1 is being studied as a potential target for mitochondrial-related diseases, but direct pharmacological modulators are in early-stage research.
Inhibition of phosphatidylglycerol phosphate dephosphorylation, impacting cardiolipin biosynthesis. General mechanisms for PTP inhibitors: block dephosphorylation activity, modulate mitochondrial lipid metabolism.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase localized to the mitochondrion 1 (PTPMT1).